Review 1: "A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals"
Year: 2024
Type: peer-review
Abstract: Reviewers generally support the study's methodology and findings but raise concerns about the neutralization data's precision and the presence of polyethylene glycol (PEG) in the vaccine formulation, which led to an adverse reaction in the phase 1 clinical trial.
Author: Xueling Wu
Institution: Columbia University
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4395115880